| Unsubscribe |
Editor's Note: See the following from our friend Josh Baylin. Josh is one of the greatest tech investors in America. For years, he helped manage $200 million at SAC Capital (the elite fund run by Steve Cohen, who owns the NY Mets). He purchased two $60,000 Nvidia supercomputers to run his own quant fund. And he even broke tech stories at Bloomberg for many years. But what he's sharing next could be the biggest call of his career...
In the biggest federal push since the Apollo program that landed on the Moon...
Trump is now pouring the full support of the federal government into a new type of AI that could soon be worth 500 times more than ChatGPT.
It works 10,000 times faster than human PhDs... and Elon Musk calls the underlying tech "the most disruptive force in history."
And it turns out... without the public knowing it... billionaire Sam Altman was behind this all along.
Sam Altman, of course, oversaw the launch of ChatGPT – the most successful tech product launch of all time... and the fastest tech app ever to reach 1 billion users.
But now... with the help of Donald Trump... Sam Altman is moving to his next big launch that could eclipse anything he's done so far at OpenAI – many times over.
And this could be the best thing to ever happen to you and your portfolio – if you take the right steps today.
Click here to learn about the #1 stock to own as Trump backs Sam Altman's Next Venture.
Regards,
Josh Baylin
Senior Analyst, Stansberry Research
P.S. This AI is 10,000 times faster than even the smartest, most well-funded human scientists on earth. The printing press was only 80 times faster than copying books by hand. Trains were just 17 times faster than horse-drawn wagons. So when I say AI is 10,000 times faster than human scientists at discovering new medicines... I understand that number is hard to comprehend. But that's the kind of exponential progress we're now living through thanks to AI. And it's why you need to move fast here. Click here to see how you can invest in AI's next major leap forward.
5 Stocks the Market Rewarded After Strong Earnings Results
Authored by Ryan Hasson. Published: 8/10/2026.
Key Points
- Amazon, Microsoft, JPMorgan Chase, Johnson & Johnson, and Coca-Cola all posted strong earnings beats and their stocks held or extended gains afterward.
- Amazon's AWS and Microsoft's Azure both showed accelerating growth, easing investor concerns that heavy AI capital spending was outpacing monetization.
- JPMorgan, Johnson & Johnson, and Coca-Cola each raised guidance or capital returns, showing resilient demand and pricing power across financials and defensive sectors.
- Special Report: Everyone wanted SpaceX. Smart money wants this.
This earnings season has delivered a hard lesson: beating estimates is no longer enough. Several richly valued names posted strong quarters, only to sell off sharply as the market picked apart their guidance, bookings or spending plans. That makes the stocks that beat expectations and either held their gains or extended them worth watching closely. When a stock absorbs good news and keeps climbing while the broader tape wobbles, it often means institutional money is genuinely accumulating shares rather than selling into strength.
Five names stand out right now, spanning several sectors, and each earned its resilience with results that answered the market's biggest questions. For investors hunting for durable leadership in a choppy market, these five names are worth a closer look.
Amazon: The $200 Billion Quarter That Reset the AI Debate
How one AI fund pays investors every Thursday (Ad)
One small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling shares or trading options, but simply by holding the fund and letting it pay out cash every Thursday.
That works out to a 34% annualized distribution rate, even though the underlying AI stocks pay no dividends themselves.
Tim Plaehn, Chief Income Strategist at Investors Alley, breaks down exactly how the fund generates these weekly payouts.
Watch the free presentation to see how the payouts workAmazon (NASDAQ: AMZN) is up close to 19% year to date, ranking among the top-rated names in the entire consumer discretionary sector according to MarketBeat's MarketRank. Its Q2 report explains why the strength has persisted. Revenue crossed $200 billion in a single quarter for the first time in company history, rising 20% year over year to $200.6 billion. AWS was the star, accelerating to 37% growth—its fastest pace in 18 quarters—and demolishing the 31% analysts expected. AWS's operating income of $16.6 billion crushed the roughly $13.6 billion consensus, while its cloud backlog reached a staggering $496 billion.
Two pieces of management commentary did the heavy lifting. CEO Andy Jassy revealed that Amazon's AI and chip businesses have each eclipsed $25 billion in annualized revenue, and he told investors that AWS could eventually become a trillion-dollar annual revenue business. That reframed the roughly $220 billion capital expenditure (CapEx) plan as a response to demand rather than a leap of faith. The stock surged more than 10% on the report, then hit a record high and crossed the $3 trillion valuation mark before dipping back to $2.96 trillion. The consensus among 59 analysts is Moderate Buy, with a price target of $322.56 implying almost 18% upside potential. From a technical perspective, the stock has digested its earnings surge well, and a break above $280 could mark the start of a fresh leg higher.
Microsoft: From Worst in the Mag 7 to a Vertical Recovery
Microsoft (NASDAQ: MSFT) tells the season's most dramatic before-and-after story. The stock entered its July 29 report down close to 19% for the year, making it the clear laggard among mega-cap technology names. It had been weighed down by fears that AI spending was outpacing monetization. Then one report changed everything. Q4 fiscal year 2026 revenue of $90.01 billion grew almost 18% and beat the $87.6 billion consensus, while adjusted earnings per share (EPS) of $4.74 topped the $4.24 estimate. However, investors should note that investment gains tied to its Anthropic and OpenAI stakes contributed meaningfully to the beat.
The core of the story was Azure, which accelerated to 43% growth and crossed $100 billion in annual revenue for the first time in company history. Microsoft 365 Copilot surpassed 30 million paid seats, evidence that enterprise AI adoption is translating into real subscription revenue. Critically, CFO Amy Hood told investors that the calendar 2026 CapEx forecast remains unchanged, removing the single biggest overhang on the stock.
Shares surged after the release, added hundreds of billions of dollars in market value within days, and have rallied roughly 28% over the past month. The consensus among 47 analysts is Moderate Buy, with a $558.87 target implying close to 12% upside. The stock is slightly overbought, however, so investors looking to enter MSFT might be better off waiting for a measured pullback and confirmation of a higher low within its new uptrend.
JPMorgan Chase: The Bank Leading the Market's Quiet Rotation
JPMorgan Chase (NYSE: JPM) is up over 10% year to date, comfortably ahead of the financial sector benchmark. It trades within about 2% of its 52-week high, with a market cap approaching the unprecedented $1 trillion mark for a U.S. bank. The Q2 report on July 14 was the catalyst that kicked off the run. Revenue of almost $58 billion and EPS of $6.14 blew past expectations, driven by strong loan growth and what is shaping up to be a record year for Wall Street's trading desks.
The capital return story adds a second leg. Having cleared the Fed's stress test, JPMorgan is widely expected to deliver a double-digit dividend increase in September, layering income growth on top of price strength. The analyst community has leaned in, with Deutsche Bank upgrading the stock from Hold to Buy with a $375 target in late July. With a strong dividend rating, outlier sector performance and relative strength, and financials showing genuine leadership as pockets of technology correct, JPMorgan remains the sector's standard-bearer.
Johnson & Johnson: A Raised Outlook and a Historic Milestone in Sight
Johnson & Johnson (NYSE: JNJ) is up more than 25% year to date, one of the strongest showings among mega-cap healthcare names and a remarkable run for a stock with one of the market's lowest volatility profiles. The Q2 report on July 15 delivered a clean beat, with adjusted EPS of $2.90 topping the $2.85 consensus and revenue of $25.31 billion rising 6.6% to exceed estimates. Management raised full-year guidance on both lines and confirmed that the company is on track to surpass $100 billion in annual revenue for the first time in its 140-year history.
The standout detail was the immunology drug Tremfya, which generated $2 billion in quarterly sales, up 72.5% and well above the roughly $1.74 billion analysts had modeled. That eased fears about erosion from Stelara biosimilars. Analysts hold a consensus Moderate Buy rating with an average target price near $268.22, implying nearly 4% upside potential, and the dividend has now been raised for more than six consecutive decades. It’s clear from the chart that JNJ has strong momentum. The stock is holding well above all its key moving averages and trading roughly 5.5% below its 52-week high. Key levels to watch are the $250 support area and the $270 resistance level, which is also a potential breakout point.
Coca-Cola: Volume Strength Not Seen in 17 Years
Coca-Cola (NYSE: KO) is up close to 25% year to date, several times the gain of the consumer staples benchmark, and its July 28 report showed why the momentum is fundamental rather than merely the result of a defensive rotation. Comparable EPS of 97 cents grew 11% and beat the 93-cent consensus, while revenue of $13.37 billion rose 6.2% and also topped estimates, extending a beat streak that now spans five straight quarters. The stock jumped 5% on the day, reaching a fresh 52-week high.
The detail that caught Wall Street's attention was volume. Trademark Coca-Cola volume grew 5% across all geographic segments, the strongest growth in 17 years outside the COVID recovery. Coca-Cola Zero Sugar surged 16%, while the FIFA World Cup activation provided a global tailwind. Notably, management raised full-year guidance to 9%-10% comparable EPS growth. For a 64-year Dividend King yielding close to 2.5%, that is growth-stock behavior from a defensive stalwart. Analysts are bullish on the name, with a consensus Moderate Buy rating and a price target implying nearly 10% upside despite its already impressive year-to-date gains. From a technical perspective, the stock is shaping up for further upside, with the key breakout level near $88 suggesting that momentum in the uptrend is continuing.
The Rewarded Few
The common thread across these five is not sector or style. It is that each report answered the exact question the market was asking. Amazon and Microsoft have shown that AI spending is translating into accelerating cloud revenue growth. JPMorgan demonstrated that the financial system is compounding through the rate cycle. Johnson & Johnson and Coca-Cola showed that pricing power and pipelines still drive growth in defensive franchises. In a season when beats alone have been sold, the market is paying up for answers—and these five delivered them. For investors, the watchlist writes itself. The entries, as always, come down to the technicals.
AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Submitted by Thomas Hughes. First Published: 8/8/2026.
Key Points
- AppLovin shares hit a 52-week low after Q2 earnings missed consensus growth targets slightly, despite strong revenue growth and high profit margins.
- Analysts trimmed price targets but maintained a Moderate Buy consensus rating, citing AppLovin's long-term cash flow and capital return potential.
- AppLovin's biggest risk is diversifying beyond gaming clients through its Axon platform, while its balance sheet remains strong with low leverage.
- Special Report: Everyone wanted SpaceX. Smart money wants this.
AppLovin’s (NASDAQ: APP) stock price plummeted to a 52-week low following the Q2 earnings report, as the market focused on near-term headwinds and timing rather than the company’s impressive growth, high margins, cash flow and capital returns.
Among AppLovin’s challenges are the slow rollout of next-generation tools and sluggish performance in legacy segments. Offsetting factors include double-digit growth, strong margins and an outlook for sustained growth that supports its buyback plans.
How one AI fund pays investors every Thursday (Ad)
One small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling shares or trading options, but simply by holding the fund and letting it pay out cash every Thursday.
That works out to a 34% annualized distribution rate, even though the underlying AI stocks pay no dividends themselves.
Tim Plaehn, Chief Income Strategist at Investors Alley, breaks down exactly how the fund generates these weekly payouts.
Watch the free presentation to see how the payouts workAppLovin is not what it used to be—and it certainly is not what many investors fear: a mobile gaming app company. Instead, it is a pure-play advertising platform that requires little to no capital expenditure to sustain and drive growth, allowing it to convert business directly into free cash flow.
Free cash flow topped $860 million in Q2, enabling a robust buyback at an ultra-safe level of about 63% of quarterly free cash flow. That was sufficient to reduce the share count by approximately 1.5% on average year over year (YOY) and 1.6% year to date.
Strong Margins, But Expectations Were Stronger
AppLovin had a solid quarter, but the trouble starts with expectations. The market had set a high bar, with forecasts rising substantially on a trailing 12-month basis and calling for more than 60% YOY growth at the high end. The company failed to reach the consensus target, triggering selling, although the miss was relatively modest. Revenue still grew by more than 50% YOY, while margin strength helped offset the shortfall.
Margins are the story with AppLovin. The company’s gross margin came in near 88% for the quarter, with a GAAP operating margin of nearly 78% and ample free cash flow conversion. Free cash flow was approximately 45% of revenue, down YOY because of timing, but it typically runs above 70%.
Near-term hurdles include the high cost of AI development, but that is a passing concern expected to fade over time as revenue and operational quality improve.
The company’s guidance failed to impress the market but included an outlook for substantial growth and healthy margins. The miss was also relatively small. The market’s response to the release is likely an overreaction that could give way to more bullish behavior in the coming quarters.
Triggers for a rebound could include sustained growth and outperformance as AppLovin’s AI investments slow and become monetized. While the Q2 report may not have produced a stock price catalyst, market-moving news is likely by early 2027.
Analysts Trim Targets for AppLovin But Remain Optimistic Long-Term
Analysts’ responses following the release highlight the disconnect between AppLovin’s near- and long-term outlooks. While the group focused on near-term headwinds and slashed price targets, their commentary invariably turned to the long-term outlook for cash flow and capital returns.
The consensus price target plummeted, but the rating remains firm at Moderate Buy. The data shows a 71% buy-side bias, and no Sell ratings are logged.
Although lower, the consensus continues to forecast substantial upside relative to early August’s low, which coincidentally aligns with a prior price-congestion band and the long-term 150-week EMA. The likely outcome is that the 2026 correction has run its course and will begin to show signs of a bottom by year-end. Potential signs of strength include the MACD, which is diverging from the new stock price low.
Factors limiting downside risk in the second half of the year include the range of analysts’ targets, which puts a floor at $340, and institutional buying.
Institutions own only 40% of the stock, but they have been aggressively accumulating shares, while the remainder of the stock is tightly held.
The company’s biggest risk is executing its non-gaming pivot. AppLovin is not a gaming app, but it has a high concentration of clients in that sector and is working to diversify its business.
Evidence that its Axon platform can capture market share in non-gaming verticals would strengthen its outlook by expanding its addressable market. The catalyst for the stock will be a shift in analysts’ sentiment and revenue forecasts, which currently point to slowing growth in the coming years.
AppLovin’s balance sheet raises no red flags. Highlights at the end of last quarter included increased cash, a cash balance nearly equal to its debt, low leverage relative to equity and rising equity despite the share-count reduction. Investors can expect more of the same in the coming quarters and years.
This email is a paid advertisement provided by Stansberry Research, a third-party advertiser of DividendStocks.com and MarketBeat.
This ad is sent on behalf of Stansberry Research, 1125 N Charles St, Baltimore, MD 21201. If you would like to optout from receiving offers from Stansberry Research please click here.
If you need assistance with your newsletter, please email our South Dakota based support team at contact@marketbeat.com.
If you no longer wish to receive email from DividendStocks.com, you can unsubscribe.
© 2006-2026 MarketBeat Media, LLC.
345 North Reid Place #620, Sioux Falls, S.D. 57103-7078. U.S.A..
No comments:
Post a Comment